Szpital Kliniczny Im. Dr. Józefa Babińskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej W Krakowie
Kraków, Poland
Treatment & access
- Treatments offeredEsketamine nasal spray (Spravato®)
- Access routeCovered by a national programme
- Cost & coverage (registry status)Covered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 12 652 43 21
- Websitehttps://babinski.pl/
Related listings
These records belong to the same organisation. They are listed separately because each is a distinct programme or location.
- Another programme at this clinicSzpital Kliniczny Im. Dr. Józefa Babińskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej W Krakowie : Spravato®
About this provider
Szpital Kliniczny im. dr. Józefa Babińskiego is Kraków's specialist psychiatric clinical hospital (SP ZOZ), based at ul. Babińskiego 29 in the Podgórze district. Per NFZ data it runs program B.147 (fully funded esketamine (Spravato) for treatment-resistant depression) with no queue reported as of June 2026, and the hospital publishes the program description on its own website. This entry is the inpatient psychiatric ward contact point; the hospital also operates mental health outpatient clinics and a psychological clinic for children and adolescents in Kraków-Podgórze.
Services & programs
- Inpatient psychiatric wards (including Psychiatric Ward I)
- Mental health outpatient clinics (Poradnia Zdrowia Psychicznego)
- Psychological outpatient clinic for children and adolescents (Kraków-Podgórze)
- NFZ drug program B.147, esketamine for treatment-resistant depression (program description published by the hospital)
Common questions
How do I enroll in the esketamine program at the Babiński Hospital?
You need a doctor's referral; qualification is carried out by the hospital's psychiatrists. The program contact points are the Psychiatric Ward (registration +48 12 652 43 21) and the Mental Health Clinic (+48 12 652 45 70), both at ul. Babińskiego 29.
Who qualifies for program B.147?
Adults aged 18-75 with confirmed moderate-to-severe depression that has not improved after at least two different antidepressants used per Polish Psychiatric Society recommendations. Final qualification is decided by the program physicians.
Is the treatment free and how is it given?
Yes, the program is fully funded by the NFZ for insured patients. Esketamine is a nasal spray self-administered under staff supervision at the hospital, taken together with a prescribed oral SSRI/SNRI antidepressant, for up to 34 weeks.
1 more verified providers within 50 km
- Chrzanów · 38 kmSzpital Powiatowy W Chrzanowie : Spravato®
Verification
- License / registryNFZ B.147
- Official registryhttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84&provider=Szpital%20Kliniczny%20Im.%20Dr.%20J%C3%B3zefa%20Babi%C5%84skiego%20Samodzielny%20Publiczny%20Zak%C5%82ad%20Opieki%20Zdrowotnej%20W%20Krakowie&format=json
- Last verified
Check your fit & enquire
Check my fit & enquireWhat to prepare before you enquire
- A referral or the contact details of your treating clinician
- A list of medications you have tried (names, doses, duration)
- A short diagnosis summary or discharge letters